Brief: Lipidor Says Still Sees Potential in AKP02
15/11/2022 07:12
Nov 15 (Reuters) - Lipidor AB LIPI.ST :
* LIPIDOR PROVIDES UPDATE FOLLOWING OUTCOME OF PHASE III
STUDY OF
PSORIASIS CANDIDATE AKP02
* COMPANY'S ASSESSMENT IS THAT AKP02 STILL HAS SIGNIFICANT
POTENTIAL AND GOAL IS TO CONTINUE TO REALIZE THAT VALUE
* WORK IS UNDERWAY TO INVESTIGATE CONDITIONS FOR THIS, WHICH
INCLUDES STRATEGY AND FINANCING
Source text for Eikon: ID:nMFNjSbpj
Further company coverage: LIPI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))